Clinical Trial Update: Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma [NA]

View source ↗

Summary

This entry reports a clinical trial evaluating the combination of transarterial chemoembolization (TACE) with apatinib for hepatocellular carcinoma; no status o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: UNKNOWN